Clinical study of chronic eczema topical compound Coptis ointment

The out use of compound Coptis onintment to control Chronic eczema the state of "shiduyunfu" Randomized controlled clinical study

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15005880

Enrollment

Unknown

Registered

2015-01-24

Start date

2015-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic eczema

Interventions

Two groups:compound Coptis ointment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: To be met both diagnostic standards of Western medicine and the Chinese medicine "wet sores" coercive wet coalescence of eczema; To be aged between 18 to 65 years old; To be with a moderate lesion of severity of the disease (BSA 5%~10%).

Exclusion criteria

Exclusion criteria: To be complicated with cardiovascular, liver and kidney, endocrine, hematopoietic system severe primary disease, or mental disorders influence experiment completed etc.; Pregnant or lactating women; Known or suspected allergy to the study drug ingredients; Difficulty to breath, tightness in the chest, palpitation, shortness of breath, nausea, vomiting, dizziness and other system symptoms; Patient attending other drug clinical trials in the same time; Patient to be considered not suit for participation of the study.

Design outcomes

Primary

Measure	Time frame
The skin test capacity;Try a light readings liposuction;A suction after the skin deformation test;Zinc hot hidden force test;	—

Contacts

Public ContactShun Liyun

doctorsunny@sina.com+86 13521779789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026